Venture Planning Group

Venture Planning Group is an international market research, publishing and management consulting firm, providing syndicated and custom services to corporate executives and key decision-makers in the healthcare, biotechnology, chemical, food and beverage, electronics, and other industries. The company’s services include:
  • Market Intelligence Surveys
  • Opportunities Analyses
  • New Technology/Product Assessments
  • Acquisitions/Joint Venture Evaluations
During the course of numerous proprietary single-client consulting assignments and over 10
0 multi-client studies, VPG has developed an extensive database on various industries, technologies, markets, companies, products, and executives worldwide.

VPG has served over 1,000 corporations in 70 countries, and has established a broad network of domestic and international contacts with industry executives, opinion leaders, and experts from leading universities, research centers, the financial community and the government.

Venture Planning Group
 

List of reports from Venture Planning Group

< prev 1  2  3  4  5  6  7  8  9  10  next >
2013 Leading Agrochemical Companies Technological Know-How
12/18/2012 | published by: Venture Planning Group
... The companies analyzed in the report include BASF, Bayer, Dow, DuPont, Makhteshim-Agan, Monsanto, Nufarm, Sumitomo, and Syngenta. Contains 26 pages Please note: The delivery time for the electronic version of this report is between 1-3 ...  |  more...
$1,750.00
2013 Global Agrochemical Companies Marketing Strategies
12/18/2012 | published by: Venture Planning Group
... Dow, DuPont, Makhteshim-Agan, Monsanto, Nufarm, Sumitomo, and Syngenta. Contains 30 pages Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated ...  |  more...
$1,850.00
2013 Leading Agrochemical Companies Strategic Directions
12/18/2012 | published by: Venture Planning Group
... divestitures. The companies analyzed in the report include BASF, Bayer, Dow, DuPont, Makhteshim-Agan, Monsanto, Nufarm, Sumitomo, and Syngenta. Contains 47 pages Please note: The delivery time for the electronic version of this report is between ...  |  more...
$1,850.00
Japan Microbiology Testing Market: Innovative Technologies and Emerging Business Opportunities
12/13/2012 | published by: Venture Planning Group
... during the next ten years. Current scientific views on the definition, epidemiology, and etiology of major infectious diseases and microorganisms. Ten-year test volume and sales forecasts for nearly 80 microbiology tests performed in Japanese hospitals, ...  |  more...
$7,800.00
UK Molecular Diagnostics Market: Innovative Technologies and Emerging Business Opportunities
12/13/2012 | published by: Venture Planning Group
... demographic, social and technological trends with significant market impact during the next ten years. An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods. Ten-year ...  |  more...
$5,900.00
Japan Tumor Marker Testing Market: Innovative Technologies and Emerging Business Opportunities
12/13/2012 | published by: Venture Planning Group
... during the next ten years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. ...  |  more...
$6,700.00
European Transfusion Diagnostics Testing Market: Innovative Technologies and Emerging Business Opportunities
12/13/2012 | published by: Venture Planning Group
... during the next ten years. Current scientific views on the definition, epidemiology, and etiology of major infectious diseases and microorganisms. Ten-year test volume and sales forecasts for nearly 80 microbiology tests performed in Japanese hospitals, ...  |  more...
$18,500.00
France Microbiology Testing Market: Innovative Technologies and Emerging Business Opportunities
12/13/2012 | published by: Venture Planning Group
... impact during the next ten years. An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods. Ten-year test volume and reagent sales forecasts for the ...  |  more...
$5,900.00
France Molecular Diagnostics Market: Innovative Technologies and Emerging Business Opportunities
12/13/2012 | published by: Venture Planning Group
... demographic, social and technological trends with significant market impact during the next ten years. An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods. Ten-year ...  |  more...
$5,900.00
France Nucleic Acid Testing Market: Innovative Technologies and Emerging Business Opportunities
12/13/2012 | published by: Venture Planning Group
... impact during the next ten years. An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods. Ten-year test volume and reagent sales forecasts for the ...  |  more...
$5,900.00
UK Microbiology Testing Market: Innovative Technologies and Emerging Business Opportunities
12/13/2012 | published by: Venture Planning Group
... during the next ten years. Current scientific views on the definition, epidemiology, and etiology of major infectious diseases and microorganisms. Ten-year test volume and sales forecasts for nearly 80 microbiology tests performed in UK hospitals, ...  |  more...
$5,900.00
US Molecular Diagnostics Market: Innovative Technologies and Emerging Business Opportunities
12/13/2012 | published by: Venture Planning Group
... demographic, social and technological trends with significant market impact during the next ten years. An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods. Ten-year ...  |  more...
$8,400.00
Spain Nucleic Acid Testing Market: Innovative Technologies and Emerging Business Opportunities
12/13/2012 | published by: Venture Planning Group
... impact during the next ten years. An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods. Ten-year test volume and reagent sales forecasts for the ...  |  more...
$5,900.00
Tumor Markers: Innovative Technologies and Emerging Business Opportunities
12/13/2012 | published by: Venture Planning Group
... basis of the disease. During the next ten years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic ...  |  more...
$28,500.00
UK Nucleic Acid Testing Market: Innovative Technologies and Emerging Business Opportunities
12/13/2012 | published by: Venture Planning Group
... impact during the next ten years. An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods. Ten-year test volume and reagent sales forecasts for the ...  |  more...
$5,900.00
UK Transfusion Diagnostic Testing Market: Innovative Technologies and Emerging Business Opportunities
12/13/2012 | published by: Venture Planning Group
... impact during the next ten years. Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in UK transfusion testing hospitals, and commercial laboratories. Annual placements ...  |  more...
$5,400.00
UK Tumor Marker Testing Market: Innovative Technologies and Emerging Business Opportunities
12/13/2012 | published by: Venture Planning Group
... during the next ten years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. ...  |  more...
$5,400.00
US Tumor Marker Testing Market: Innovative Technologies and Emerging Business Opportunities
12/13/2012 | published by: Venture Planning Group
... during the next ten years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. ...  |  more...
$8,700.00
France Tumor Marker Testing Market: Innovative Technologies and Emerging Business Opportunities
12/13/2012 | published by: Venture Planning Group
... during the next ten years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. ...  |  more...
$5,400.00
Germany Transfusion Diagnostic Testing Market: Innovative Technologies and Emerging Business Opportunities
12/13/2012 | published by: Venture Planning Group
... impact during the next ten years. Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in German transfusion testing hospitals, and commercial laboratories. Annual placements ...  |  more...
$5,400.00
Germany Tumor Marker Testing Market: Innovative Technologies and Emerging Business Opportunities
12/13/2012 | published by: Venture Planning Group
... during the next ten years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. ...  |  more...
$5,400.00
Global Nucleic Acid Testing Market: Innovative Technologies and Emerging Business Opportunities
12/13/2012 | published by: Venture Planning Group
... technological trends in seven major markets - Five- and ten-year test volume and sales forecasts - Market shares of leading competitors - Feature comparison of major analyzers - Profiles of market players and start-up firms ...  |  more...
$28,500.00
Italy Tumor Marker Testing Market: Innovative Technologies and Emerging Business Opportunities
12/13/2012 | published by: Venture Planning Group
... during the next ten years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. ...  |  more...
$5,400.00
Japan Nucleic Acid Testing Market: Innovative Technologies and Emerging Business Opportunities
12/13/2012 | published by: Venture Planning Group
... impact during the next ten years. An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods. Ten-year test volume and reagent sales forecasts for the ...  |  more...
$7,500.00
Japan Transfusion Diagnostic Testing Market: Innovative Technologies and Emerging Business Opportunities
12/13/2012 | published by: Venture Planning Group
... impact during the next ten years. Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in Japanese transfusion testing hospitals, and commercial laboratories. Annual placements ...  |  more...
$6,800.00
< prev 1  2  3  4  5  6  7  8  9  10  next >
 

Research assistance

We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 

Join Alert Me now!

Receive bi-weekly email alerts on new market research

Sign up today!